PRKD1 and familial pancreatic carcinoma: In recent years, aberrant expression and activity of PKD isoforms has been detected in various cancers, such as prostate, breast, skin or pancreatic cancer (Roy et al., 2017) making the kinase family a potential target for cancer therapy.